{"id":859321,"date":"2025-06-10T19:04:42","date_gmt":"2025-06-10T23:04:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/"},"modified":"2025-06-10T19:04:42","modified_gmt":"2025-06-10T23:04:42","slug":"prime-success-sends-letter-to-sinovac-biotech-shareholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/","title":{"rendered":"Prime Success Sends Letter to Sinovac Biotech Shareholders"},"content":{"rendered":"

<\/p>\n

Prime Success Sends Letter to Sinovac Biotech Shareholders<\/b><\/p>\n

Details Why Change is Needed on Sinovac\u2019s Board in Order to Restore Company\u2019s Previous Success and Reverse Value-Destructive Path Taken Under Current Board<\/i><\/p>\n

Affirms Commitment to Seeing Company Reinstate Trading on the NASDAQ, Fairly Issue Dividends and Overhaul Corporate Governance<\/i><\/p>\n

Encourages Shareholders to Support Slate of Director Nominees Proposed by SAIF for Election at Upcoming July 8 Special Meeting<\/i><\/p>\n

For More Information, Visit <\/i>www.SaveSinovac.com<\/i><\/a><\/p>\n

HONG KONG–(BUSINESS WIRE<\/a>)–
\nPrime Success L.P., (together with its affiliates, \u201cPrime Success\u201d or \u201cwe\u201d), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d) with ownership of approximately 8% of the Company\u2019s outstanding shares, today issued a letter to shareholders in connection with the upcoming Special Meeting of Shareholders (the \u201cSpecial Meeting\u201d) scheduled for July 8, 2025.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250610033915\/en\/<\/a><\/p>\n

\nThe full text of the letter can be viewed here<\/a> and by visiting www.SaveSinovac.com<\/a>.<\/p>\n

\nIn its letter, Prime Success outlines the need for change on Sinovac\u2019s Board of Directors (the \u201cBoard\u201d) and presents key reasons to support the election of SAIF Partners IV L.P.\u2019s (\u201cSAIF\u201d) nominees, who are committed to taking the following value-enhancing actions:<\/p>\n

    \n
  1. Oversee a fair, equitable, and timely distribution of cash dividends<\/b>, including fully supporting the payment of the announced dividend of approximately $55 per share to all shareholders, but also actively advocating for the distribution of future dividends from the subsidiaries. Prime Success wants to ensure that the value accumulated in the Company under the management team\u2019s leadership over the years is rightfully returned to all shareholders in a timely manner.\n<\/li>\n
  2. Reinstate normal trading of the Company\u2019s shares on NASDAQ and stabilize operations<\/b> by resolving the uncertainty created by the current Board and taking steps to put the external auditor back on track.\n<\/li>\n
  3. Overhaul governance and rebuild investor trust<\/b> by adhering to corporate governance best practices, promoting greater transparency and enhancing board accountability.\n<\/li>\n
  4. Lay the groundwork for sustainable long-term growth <\/b>by leveraging the candidates\u2019 independence, backgrounds, and expertise to support the Company\u2019s continued development and expansion.\n<\/li>\n<\/ol>\n

    \nPrime Success contrasts this with the current Sinovac Board members, who have:<\/p>\n

      \n
    1. Taken actions leading to and prolonging the 2019 NASDAQ halt of trading in the Company\u2019s shares<\/b>, significantly harming Sinovac\u2019s growth.\n<\/li>\n
    2. Impeded the Company’s ability to issue dividends over the past seven years<\/b> through prolonged litigation stemming from 1Globe Capital LLC\u2019s (\u201c1Globe\u201d) undisclosed efforts to seize board control, causing significant shareholder harm.\n<\/li>\n
    3. Wasted Company resources on multiple<\/b>lawsuits<\/b>across various forums<\/b> at the broader shareholder base\u2019s expense.\n<\/li>\n
    4. Weaponized Sinovac\u2019s allocation of capital as part of their attempt to invalidate the shares of long-term investors<\/b> by attempting an unjust and potentially unlawful scheme of dividend distribution.\n<\/li>\n
    5. Prioritized personal interests over fiduciary obligations to all shareholders<\/b> by seeking to void the Company\u2019s contractual obligations to benefit current Board members.\n<\/li>\n
    6. Created significant operational uncertainty by attempting to invalidate the decisions made by the prior Board that directly led to the Company\u2019s tremendous global commercial success in the past few years<\/b>, resulting in the resignation of Sinovac\u2019s external auditor.\n<\/li>\n
    7. Alienated management<\/b>to such a significant degree<\/b> that the Sinovac management team issued an unprecedented public statement calling for a new Board election.1<\/sup><\/li>\n
    8. Appointed directors with flawed ethics through questionable and potentially unlawful procedures, <\/b>resulting in disproportionate representation of investors and eroding shareholder trust.\n<\/li>\n<\/ol>\n

      \nPrime Success shares its belief that supporting SAIF\u2019s slate is essential for the future success of Sinovac and encourages shareholders to wait for and read SAIF\u2019s proxy materials before voting for the Special Meeting on July 8, 2025.<\/p>\n

      About Prime Success, L.P.<\/b><\/p>\n

      \nPrime Success is an investment vehicle established by Advantech Capital specifically to invest in Sinovac and Sinovac Life Sciences; Advantech Capital is a private equity fund established in 2016 with a focus on innovation-driven growth opportunities in China.<\/p>\n\n\n\n
      ____________________________________<\/td>\n<\/tr>\n
      \n

      1<\/sup> Press Release: SINOVAC Management Statement Regarding Auditor Resignation (April 22, 2025)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

      \n\u00a0<\/p>\n

      \"\"<\/p>\n

      View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250610033915\/en\/<\/a><\/span><\/p>\n

      Media Contact
      \n<\/b>
      Longacre Square Partners
      \n
      Dan Zacchei \/ Miller Winston
      \n
      advantech@longacresquare.com<\/a><\/p>\n

      KEYWORDS:<\/b> Asia Pacific Hong Kong<\/p>\n

      INDUSTRY KEYWORDS:<\/b> Asset Management Professional Services Finance<\/p>\n

      MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

      Prime Success Sends Letter to Sinovac Biotech Shareholders Details Why Change is Needed on Sinovac\u2019s Board in Order to Restore Company\u2019s Previous Success and Reverse Value-Destructive Path Taken Under Current Board Affirms Commitment to Seeing Company Reinstate Trading on the NASDAQ, Fairly Issue Dividends and Overhaul Corporate Governance Encourages Shareholders to Support Slate of Director Nominees Proposed by SAIF for Election at Upcoming July 8 Special Meeting For More Information, Visit www.SaveSinovac.com HONG KONG–(BUSINESS WIRE)– Prime Success L.P., (together with its affiliates, \u201cPrime Success\u201d or \u201cwe\u201d), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d) with ownership of approximately 8% of the Company\u2019s outstanding shares, today issued a letter to shareholders in connection with the upcoming … <\/p>\n

      Continue reading “Prime Success Sends Letter to Sinovac Biotech Shareholders”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-859321","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPrime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Prime Success Sends Letter to Sinovac Biotech Shareholders Details Why Change is Needed on Sinovac\u2019s Board in Order to Restore Company\u2019s Previous Success and Reverse Value-Destructive Path Taken Under Current Board Affirms Commitment to Seeing Company Reinstate Trading on the NASDAQ, Fairly Issue Dividends and Overhaul Corporate Governance Encourages Shareholders to Support Slate of Director Nominees Proposed by SAIF for Election at Upcoming July 8 Special Meeting For More Information, Visit www.SaveSinovac.com HONG KONG–(BUSINESS WIRE)– Prime Success L.P., (together with its affiliates, \u201cPrime Success\u201d or \u201cwe\u201d), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d) with ownership of approximately 8% of the Company\u2019s outstanding shares, today issued a letter to shareholders in connection with the upcoming … Continue reading "Prime Success Sends Letter to Sinovac Biotech Shareholders"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T23:04:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Prime Success Sends Letter to Sinovac Biotech Shareholders\",\"datePublished\":\"2025-06-10T23:04:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/\"},\"wordCount\":712,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/\",\"name\":\"Prime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-06-10T23:04:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prime-success-sends-letter-to-sinovac-biotech-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prime Success Sends Letter to Sinovac Biotech Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Prime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk","og_description":"Prime Success Sends Letter to Sinovac Biotech Shareholders Details Why Change is Needed on Sinovac\u2019s Board in Order to Restore Company\u2019s Previous Success and Reverse Value-Destructive Path Taken Under Current Board Affirms Commitment to Seeing Company Reinstate Trading on the NASDAQ, Fairly Issue Dividends and Overhaul Corporate Governance Encourages Shareholders to Support Slate of Director Nominees Proposed by SAIF for Election at Upcoming July 8 Special Meeting For More Information, Visit www.SaveSinovac.com HONG KONG–(BUSINESS WIRE)– Prime Success L.P., (together with its affiliates, \u201cPrime Success\u201d or \u201cwe\u201d), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d) with ownership of approximately 8% of the Company\u2019s outstanding shares, today issued a letter to shareholders in connection with the upcoming … Continue reading \"Prime Success Sends Letter to Sinovac Biotech Shareholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-10T23:04:42+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Prime Success Sends Letter to Sinovac Biotech Shareholders","datePublished":"2025-06-10T23:04:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/"},"wordCount":712,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/","name":"Prime Success Sends Letter to Sinovac Biotech Shareholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-06-10T23:04:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250610033915r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prime-success-sends-letter-to-sinovac-biotech-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Prime Success Sends Letter to Sinovac Biotech Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=859321"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859321\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=859321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=859321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=859321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}